Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | The Evolving Global Meeting Management Strategy (PH111)

The Evolving Global Meeting Management Strategy (PH111)

Improve meeting planning efficiency to win physician attendance

In today’s competitive environment, meeting planners in the life sciences industries are increasingly required to take on greater responsibilities. No longer relegated to marketing support personnel, meeting planners now play a strategic role. To bolster this transition, most companies employ centralized structures for their meeting planning departments. More than ever before, meeting planners interact with and serve an entire organization.

Written in Collaboration with:

Becoming a strategic function provides key advantages for meeting management, but the change also brings new challenges on top of complex compliance-related issues. By and large, regulatory pressures have dramatically altered companies’ meeting management practices—from selecting meeting sites, to tracking physician spending, and attracting doctors to attend.

This study culminates a yearlong collaboration between Cutting Edge Information, Medical Meetings magazine and the Center for Business Intelligence. The report reveals critical trends across the pharmaceutical, biotech, and medical device industries. Use the report’s hard-to-find benchmarking data and in-depth analysis to take meeting management to the next level:

* Overcome compliance-related roadblocks

* Coordinate global compliance

* Balance internal and external customer demands

* Boost meeting attendance and participation

* Forge successful relationships with vendors

Companies Included in Report

Abbott Laboratories

Amgen

BARD Urological Division

Biogen Idec

Bristol-Myers Squibb

Eli Lilly

EMD Serono

Holland & Knight

Hospira

Human Genome Sciences

Johnson & Johnson

Medtronic

Merck

Merck Serono

Pioneer Surgical Technology

Roche

Schering-Plough

Stiefel Labs

Stryker Spine

Takeda

Wyeth

Published 2008

138 Pages

250+ Metrics

106 Charts and Diagrams
Table of Contents
Price: $995.00 / €665.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions